Literature DB >> 26530488

[Differential diagnostics of hypomelanoses].

M Böhm1.   

Abstract

Hypomelanoses of the skin encompass a wide spectrum of congenital and acquired alterations in melanin pigmentation. These diseases can be localized or universal. The pathobiology of cutaneous hypomelanoses is heterogeneous and includes defects in melanoblast migration from the neural crest to the epidermis, alterations in melanogenesis and melanin transfer to keratinocytes, and destruction of pigment cells by autoimmune and inflammatory processes. Importantly, some congenital forms of universal hypomelanoses are associated with involvement of internal organs (e.g., Hermansky-Pudlack or Chédiak-Higashi syndrome) and require interdisciplinary patient management. In recent years, significant progress has been made in our current understanding of the pathophysiology especially of vitiligo, thus, resulting in promising new treatment strategies. This disease being one of the most common forms of acquired hypomelanoses of the skin can now be treated in a guideline-oriented and evidence-based manner.

Entities:  

Keywords:  Albinisms; Melanin; Melanoblast; Melanogenesis; Vitiligo

Mesh:

Substances:

Year:  2015        PMID: 26530488     DOI: 10.1007/s00105-015-3717-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  Narrowband UVB treatment of progressive macular hypomelanosis.

Authors:  Moon-Bum Kim; Gun-Wook Kim; Hyun-Ho Cho; Hyun-Je Park; Hoon-Soo Kim; Su-Han Kim; Byung-Soo Kim; Hyun-Chang Ko
Journal:  J Am Acad Dermatol       Date:  2011-10-17       Impact factor: 11.527

2.  Hypomelanosis of Ito: pigmentary mosaicism with immature melanosome in keratinocytes.

Authors:  Céline Devillers; Pascale Quatresooz; Trinh Hermanns-Lê; Gregory Szepetiuk; Roland Lemaire; Claudine Piérard-Franchimont; Gérald E Piérard
Journal:  Int J Dermatol       Date:  2011-10       Impact factor: 2.736

Review 3.  A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes.

Authors:  Clio Dessinioti; Alexander J Stratigos; Dimitris Rigopoulos; Andreas D Katsambas
Journal:  Exp Dermatol       Date:  2009-06-23       Impact factor: 3.960

Review 4.  Postinflammatory hypopigmentation.

Authors:  V Vachiramon; K Thadanipon
Journal:  Clin Exp Dermatol       Date:  2011-06-14       Impact factor: 3.470

5.  Guidelines for the management of vitiligo: the European Dermatology Forum consensus.

Authors:  A Taieb; A Alomar; M Böhm; M L Dell'anna; A De Pase; V Eleftheriadou; K Ezzedine; Y Gauthier; D J Gawkrodger; T Jouary; G Leone; S Moretti; L Nieuweboer-Krobotova; M J Olsson; D Parsad; T Passeron; A Tanew; W van der Veen; N van Geel; M Whitton; A Wolkerstorfer; M Picardo
Journal:  Br J Dermatol       Date:  2012-11-02       Impact factor: 9.302

Review 6.  Vitiligo.

Authors:  Khaled Ezzedine; Viktoria Eleftheriadou; Maxine Whitton; Nanja van Geel
Journal:  Lancet       Date:  2015-01-15       Impact factor: 79.321

Review 7.  Piebaldism.

Authors:  Naoki Oiso; Kazuyoshi Fukai; Akira Kawada; Tamio Suzuki
Journal:  J Dermatol       Date:  2012-06-01       Impact factor: 4.005

8.  Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study.

Authors:  P Rerknimitr; W Disphanurat; M Achariyakul
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-02-10       Impact factor: 6.166

Review 9.  Griscelli Syndrome Type 3: Two New Cases and Review of the Literature.

Authors:  Ariella Nouriel; Jonah Zisquit; Alexander M Helfand; Yair Anikster; Shoshana Greenberger
Journal:  Pediatr Dermatol       Date:  2015-09-04       Impact factor: 1.588

Review 10.  Increasing the complexity: new genes and new types of albinism.

Authors:  Lluís Montoliu; Karen Grønskov; Ai-Hua Wei; Mónica Martínez-García; Almudena Fernández; Benoît Arveiler; Fanny Morice-Picard; Saima Riazuddin; Tamio Suzuki; Zubair M Ahmed; Thomas Rosenberg; Wei Li
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-17       Impact factor: 4.693

View more
  2 in total

1.  [Vitiligo: Clinical presentation and pathogenesis].

Authors:  M Schild; M Meurer
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

Review 2.  [Oculocutaneous and ocular albinism].

Authors:  A S Kubasch; M Meurer
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.